Fierce Biotech9d
'I don't feel we lost momentum': Takeda’s oncology execs sharpen focus after restructuring
Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, ...
Takeda: Buy Into Future Drug Pipeline Potential, Despite Recent Profit Headwinds
Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...
Rio Takeda of Japan shoots a blistering 8-under 64 in China to win her second LPGA title
Rio Takeda shot a blistering 8-under 64 to win the LPGA’s Blue Bay tournament by six shots ahead of Minjee Lee of Australia.
The Associated Press – Sports on MSN14d
Rio Takeda takes a 2-shot lead into the final round of the LPGA tournament in China
Rio Takeda of Japan shot a 3-under 69 to hold a two-shot lead after three rounds of the LPGA’s Blue Bay tournament on China’s ...
Rio Takeda wins Blue Bay LPGA in dominating fashion, first rookie to win on LPGA since 2023
Takeda is the second first-time winner this season, joining Yealimi Noh, who earned her first LPGA win at the Founders Cup.
Rio Takeda of Japan cards blistering 8-under 64 in China to win her second LPGA title
SANYA, China — Rio Takeda shot a blistering 8-under 64 on Sunday to win the LPGA’s Blue Bay tournament by six shots ahead of ...
Fierce Pharma8d
Fierce Pharma Asia—Takeda's oncology focus; Sun's Checkpoint buy; Ono-Ionis antisense deal
Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...
Mass. man gets prison time for defrauding Takeda Pharmaceutical Co. of $2.3M
A Massachusetts man who, along with his girlfriend, defrauded Takeda Pharmaceutical Co. of $2.3 million and used the money to ...
M&T Bank Corp Cuts Stake in Takeda Pharmaceutical Company Limited (NYSE:TAK)
M&T Bank Corp lowered its position in Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) by 10.0% in the 4th ...
Business Wire19d
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
− All four key secondary endpoints were met, including EU primary endpoint and patient-reported outcomes NEWARK, Calif. & OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Protagonist ...